What we do
Cancer is the second leading cause of death in Arizona. The American Cancer Society estimates that there will be over 40,000 new cancer cases in Arizona in 2023. Over the past 30 years, cancer mortality has steadily declined.
The primary reasons for this decline are increased cancer prevention and control (CPC), which includes early detection (e.g., biological markers), prevention (e.g., interventions or approaches to block/delay cancer), screening, health care delivery, quality of life and/or survivorship related to cancer. More specifically, improved early detection via screening (e.g., breast cancer), reductions in smoking and improvements in the quality of cancer care are major reasons for this decrease, but much more research is needed to further reduce cancer mortality, with particular focus on underserved populations because reductions have not been as great in that population.
This highly collaborative translational team fosters the advancement of cancer prevention and control research with particular emphasis on underserved populations. The team includes community partnerships (health care, nonprofits, government, business, schools) and also engages students.

